JnJ Imaavy gets USFDA okay for generalized myasthenia gravis Ruchika Sharma1 May 2025 1:15 PM ISTSpring House: Johnson & Johnson has received approval from the U.S. Food and Drug Administration (FDA) for IMAAVY (nipocalimab-aahu), a human...
FDA Approves Nipocalimab for Generalized Myasthenia Gravis Dr. Kamal Kant Kohli1 May 2025 7:00 AM ISTThe US Food and Drug Administration (FDA) has approved nipocalimab (Imaavy) injection for the treatment of adults and children aged 12 and older with...
JnJ Nipocalimab gets USFDA Priority Review designation for generalized myasthenia gravis Ruchika Sharma12 Jan 2025 3:30 PM ISTSpring House: Johnson & Johnson has announced the nipocalimab Biologics License Application (BLA) has received Priority Review designation...
JnJ seeks approval of nipocalimab to treat generalized myasthenia gravis Ruchika Sharma2 Sept 2024 4:29 PM ISTSpring House: Johnson & Johnson has announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug...
